Surrozen (SRZN)

• Market cap: $189M
• 1 day: 1.06%
• 5 days: -3.64%
• 1 month: 36.48%
• 3 months: 70.67%
• 6 months: 146.09%
• Year to date: 54.39%
• 1 year: 63.45%
• 5 years: -85.49%
• 10 years: -85.49%
• Sector: Healthcare
• Industry: Biotechnology

About: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Employees: 41